Goat anti-Golden Syrian Hamster IgG (Heavy & Light Chain) Antibody (Agarose Beads)

Catalog No. ABIN964451

Supplier Product No.: 207-1150

Product Details

Target: IgG

Binding Specificity: Heavy & Light Chain

Reactivity: Golden Syrian Hamster

Host: Goat

Clonality: Polyclonal

Conjugate: Agarose Beads

Application: Immunoprecipitation (IP)

Supplier Product No.: 207-1150

Supplier: Rockland

Purpose: Golden Syrian Hamster IgG Antibody Agarose

Cross-Reactivity (Details): Sufficient antibody capacity is provided to bind a minimum of 5 mg of pure Hamster IgG.

Characteristics: Anti-Golden Syrian Hamster IgG Antibody generated in goat detects Golden Syrian Hamster IgG.

Purification: This product is an IgG fraction antibody coupled to activated agarose.

Isotype: IgG

Application Details

Application Notes: Application Note: Anti-Golden Syrian Hamster IgG Agarose Conjugate is useful for immunoprecipitation and other immunological assays. Immunoprecipitation Dilution: User Optimized

Restrictions: For Research Use only

Handling

Buffer:

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

Stabilizer: None

, Preservative:0.01 % (w/v) Sodium Azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store vial at 4° C prior to opening. DO NOT FREEZE.

Expiry Date: 12 months

Target Details

Target: IgG

Abstract: IgG Products

Target Type: Antibody

Background: It is a protein complex composed of four peptide chains - two identical heavy chains and two identical light chains arranged in a Y-shape typical of antibody monomers. Each IgG has two antigen binding sites. Representing approximately 75 % of serum immunoglobulins in humans, IgG is the most abundant antibody isotype found in the circulation. IgG molecules are synthesized and secreted by plasma B cells. Secondary Antibodies are available in a variety of formats and conjugate types. When choosing a secondary antibody product, consideration must be given to species and immunoglobulin specificity, conjugate type, fragment and chain specificity, level of cross-reactivity, and host-species source and fragment composition.